Measles and the canonical path to elimination.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
10 05 2019
Historique:
received: 29 06 2018
accepted: 11 04 2019
entrez: 11 5 2019
pubmed: 11 5 2019
medline: 18 12 2019
Statut: ppublish

Résumé

All World Health Organization regions have set measles elimination goals. We find that as countries progress toward these goals, they undergo predictable changes in the size and frequency of measles outbreaks. A country's position on this "canonical path" is driven by both measles control activities and demographic factors, which combine to change the effective size of the measles-susceptible population, thereby driving the country through theoretically established dynamic regimes. Further, position on the path to elimination provides critical information for guiding vaccination efforts, such as the age profile of susceptibility, that could only otherwise be obtained through costly field studies or sophisticated analysis. Equipped with this information, countries can gain insight into their current and future measles epidemiology and select appropriate strategies to more quickly achieve elimination goals.

Identifiants

pubmed: 31073065
pii: 364/6440/584
doi: 10.1126/science.aau6299
pmc: PMC7745123
doi:

Substances chimiques

Measles Vaccine 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

584-587

Subventions

Organisme : NIGMS NIH HHS
ID : U01 GM110744
Pays : United States

Informations de copyright

Copyright © 2019, American Association for the Advancement of Science.

Références

Science. 2015 Mar 13;347(6227):1240-2
pubmed: 25766232
Proc Biol Sci. 1998 Feb 7;265(1392):211-20
pubmed: 9493407
Nature. 2001 Dec 13;414(6865):716-23
pubmed: 11742391
Nature. 2008 Feb 7;451(7179):679-84
pubmed: 18256664
Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):769-76
pubmed: 10365402
Epidemiol Infect. 2010 Sep;138(9):1308-16
pubmed: 20096146
Sci Rep. 2016 Apr 29;6:25248
pubmed: 27125917
Lancet. 2012 Jun 9;379(9832):2173-8
pubmed: 22534001
J Theor Biol. 1966 Jul;11(2):207-11
pubmed: 5965486

Auteurs

Matthew Graham (M)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
These authors contributed equally to this work.

Amy K Winter (AK)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
These authors contributed equally to this work.

Matthew Ferrari (M)

Department of Biology, The Pennsylvania State University, University Park, PA, USA.

Bryan Grenfell (B)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA.
Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.

William J Moss (WJ)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Andrew S Azman (AS)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

C Jessica E Metcalf (CJE)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA.

Justin Lessler (J)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. justin@jhu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH